Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Salido

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Blood Advances|October 28, 2025
OPTICAL GENOME MAPPING IN MYELOFIBROSIS: ENHANCING PROGNOSTIC ACCURACY THROUGH HIGH-RESOLUTION GENOMIC PROFILINGÁlvaro Díaz González, Elvira Mora, Marta Garrote, et al.
Oncotarget|September 15, 2017
Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of <i>TP53/ATM FISH</i> deletionsAnna Puiggros, Rosa Collado, Maria José Calasanz, et al.
Leukemia Research|January 23, 2013
Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: does -7/7q- detection by FISH have prognostic value?Vera Ademà, Jesús María Hernández, María Abáigar, et al.
Haematologica|July 2, 2008
Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-Mar Mallo, Leonor Arenillas, Blanca Espinet, et al.
Genes, Chromosomes & Cancer|February 10, 2010
Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphomaBlanca Espinet, Itziar Salaverria, Sílvia Beà, et al.
Blood Advances|May 27, 2026
Integrated multi-omic profiling reveals two distinct splenic marginal zone lymphoma subgroups with prognostic relevanceHelen Parker, Amatta Mirandari, Ben Stevens, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 27, 2019
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma: the ROSING StudyEsther Conde, Susana Hernandez, Rebeca Martinez, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Blood Advances|October 28, 2025
OPTICAL GENOME MAPPING IN MYELOFIBROSIS: ENHANCING PROGNOSTIC ACCURACY THROUGH HIGH-RESOLUTION GENOMIC PROFILINGÁlvaro Díaz González, Elvira Mora, Marta Garrote, et al.
Oncotarget|September 15, 2017
Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of <i>TP53/ATM FISH</i> deletionsAnna Puiggros, Rosa Collado, Maria José Calasanz, et al.
Leukemia Research|January 23, 2013
Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: does -7/7q- detection by FISH have prognostic value?Vera Ademà, Jesús María Hernández, María Abáigar, et al.
Haematologica|July 2, 2008
Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-Mar Mallo, Leonor Arenillas, Blanca Espinet, et al.
Genes, Chromosomes & Cancer|February 10, 2010
Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphomaBlanca Espinet, Itziar Salaverria, Sílvia Beà, et al.
Blood Advances|May 27, 2026
Integrated multi-omic profiling reveals two distinct splenic marginal zone lymphoma subgroups with prognostic relevanceHelen Parker, Amatta Mirandari, Ben Stevens, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 27, 2019
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma: the ROSING StudyEsther Conde, Susana Hernandez, Rebeca Martinez, et al.
Pageof 11